Skip to main content
logo
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
6.00
+2.15 (55.84%)
Oct 19, 2026, 11:19 AM EST

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
814287325672547715
Market Cap Growth
170.27%-11.59%-51.64%22.71%-23.44%17.04%
Enterprise Value
743185152600448612
Last Close Price
3.852.002.631.503.257.15

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
849.78513.747.5121.2325.2842.53
PB Ratio
13.584.612.4230.5420.5861.93
P/TBV Ratio
18.735.592.6157.6633.06580.25
P/FCF Ratio
-----96.09
P/OCF Ratio
-----77.58

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-331.263.5218.9720.6736.40
EV/FCF Ratio
-----82.24

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.020.020.02
Debt / FCF Ratio
-----0.03
Net Debt / Equity Ratio
-1.87-1.36-1.10-3.11-3.20-8.61
Net Debt / EBITDA Ratio
1.131.043.011.321.681.61
Net Debt / FCF Ratio
1.701.362.171.381.49-13.36
Asset Turnover
0.010.000.270.250.180.14
Quick Ratio
6.408.0610.364.154.035.41
Current Ratio
7.428.7211.144.624.415.69
Return on Equity (ROE)
-90.41%-90.27%-58.08%-223.22%-273.06%-448.22%
Return on Assets (ROA)
-29.65%-30.79%-19.24%-26.32%-26.09%-31.44%
Return on Capital Employed (ROCE)
-68.80%-69.80%-26.70%-54.00%-49.70%-56.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.47%-30.86%-13.95%-8.07%-9.20%-7.46%
FCF Yield
-8.09%-21.70%-20.89%-7.37%-10.45%1.04%
Buyback Yield / Dilution
-0.09%-2.12%-24.69%-15.21%-8.58%-8.78%